AESKU.GROUP, a leading biotechnology company, based in Wendelsheim, Germany, launched the first quantitative SARS-CoV-2 antibody tests in the 22nd calendar week. AESKU is currently the only company in the biotechnology industry, developing quantitative SARS-CoV-2 antibody tests that can certify the acquired immunity of patients or vaccinated individuals. In the current situation, there is little need to discuss […]
continue reading